nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Accelerating drug discovery, development, and clinical trials by artificial intelligence
|
Zhang, Yilun |
|
|
5 |
9 |
p. 1050-1070 |
artikel |
2 |
Adding first-line PD-1 inhibition to anti-VEGF and XELOX in pMMR metastatic colorectal cancer: Steppingstones, stumbling blocks, and next phase
|
Veen, Torhild |
|
|
5 |
9 |
p. 1041-1043 |
artikel |
3 |
EGFR-mutated NSCLC: A roadmap to treatment sequences
|
Girard, Nicolas |
|
|
5 |
9 |
p. 1044-1047 |
artikel |
4 |
Exceptional, naturally occurring HIV-1 control: Insight into a functional cure
|
Salgado, María |
|
|
5 |
9 |
p. 1071-1082 |
artikel |
5 |
Final analysis of camrelizumab plus chemotherapy for untreated advanced or metastatic esophageal squamous cell carcinoma: The ESCORT-1st trial
|
He, Mingming |
|
|
5 |
9 |
p. 1137-1149.e3 |
artikel |
6 |
First-line serplulimab in metastatic colorectal cancer: Phase 2 results of a randomized, double-blind, phase 2/3 trial
|
Wang, Zi-Xian |
|
|
5 |
9 |
p. 1150-1163.e3 |
artikel |
7 |
How to rescue a DreaMM deferred …
|
Joseph, Nisha S. |
|
|
5 |
9 |
p. 1048-1049 |
artikel |
8 |
Immune checkpoint inhibitors for first-line treatment of advanced esophageal squamous cell carcinoma
|
Alsina, Maria |
|
|
5 |
9 |
p. 1038-1040 |
artikel |
9 |
Mycoplasma genitalium in pregnancy, including specific co-infections, is associated with lower birthweight: A prospective cohort study
|
Scoullar, Michelle J.L. |
|
|
5 |
9 |
p. 1123-1136.e3 |
artikel |
10 |
Neutralizing antibodies after nebulized phage therapy in cystic fibrosis patients
|
Bernabéu-Gimeno, Mireia |
|
|
5 |
9 |
p. 1096-1111.e6 |
artikel |
11 |
Q&A with Daniel Drucker
|
Drucker, Daniel |
|
|
5 |
9 |
p. 1031-1034 |
artikel |
12 |
QUATTRO-II randomized trial: CAPOXIRI+bevacizumab vs. FOLFOXIRI+bevacizumab as first-line treatment in patients with mCRC
|
Bando, Hideaki |
|
|
5 |
9 |
p. 1164-1177.e3 |
artikel |
13 |
Shaping the future of heart health
|
Cheng, Alice Y.Y. |
|
|
5 |
9 |
p. 1035-1037 |
artikel |
14 |
SMIM1 absence is associated with reduced energy expenditure and excess weight
|
Stefanucci, Luca |
|
|
5 |
9 |
p. 1083-1095.e6 |
artikel |
15 |
Systematic analysis of levels of evidence supporting Chinese clinical practice guidelines for gastrointestinal disease
|
Han, Ke |
|
|
5 |
9 |
p. 1112-1122.e3 |
artikel |
16 |
Trofinetide for the treatment of Rett syndrome: Results from the open-label extension LILAC study
|
Percy, Alan K. |
|
|
5 |
9 |
p. 1178-1189.e3 |
artikel |